The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice

被引：1
|
作者：
Alipour, M. [1 ]
Fekrmandi, F. [2 ]
Onsori, S. [1 ]
Tabrizian, P. [1 ]
Jafari, M. R. [1 ]
机构：
[1] Zanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Zanjan 45147, Iran
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
DRUG RESEARCH | 2016年 / 66卷 / 11期
关键词：
antinociception; JWH-133; pilocarpine; atropine; formalin test; mice;
D O I：
10.1055/s-0042-112365
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
There is no published study regarding the interaction between muscarinic receptor modulators and antinociception induced by cannabinoid receptor (CB2) agonist. The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied. First the analgesic effect of JWH-133 (0.001-1mg/Kg) or pilocarpine (2.5-20mg/kg) or atropine (0.2-5mg/kg) was evaluated. Subsequently, the effect of co-administration of pilocarpine (2.5mg/kg) or atropine (5mg/kg) and JWH-133 (0.001-1mg/Kg) were studied too. JWH-133 and pilocarpine provoked antinociception in mice but atropine did not. Pilocarpine potentiated the analgesic effect of JWH-133 but atropine antagonized that. It can be concluded that JWH-133 induced antinociception is affected by muscarinic receptor modulators in mice.
引用
收藏
页码：597 / 602
页数：6
相关论文
共 50 条
  • [31] Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
    Ueda, Y
    Miyagawa, N
    Matsui, T
    Kaya, T
    Wamura, H
    Iwamura, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 520 (1-3) : 164 - 171
  • [32] Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS
    Gorantla, Santhi
    Makarov, Edward
    Roy, Deepa
    Finke-Dwyer, Jennifer
    Murrin, L. Charles
    Gendelman, Howard E.
    Poluektova, Larisa
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2010, 5 (03) : 456 - 468
  • [33] Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19
    Jha, Niraj Kumar
    Sharma, Charu
    Meeran, Mohamed Fizur Nagoor
    Jha, Saurabh Kumar
    Dwivedi, Vivek Dhar
    Gupta, Piyush Kumar
    Dey, Abhijit
    Kesari, Kavindra Kumar
    Ojha, Shreesh
    IMMUNO, 2021, 1 (03): : 285 - 304
  • [34] Characterization of the Role of Endocannabinoid System Using Jwh-133, a Selective Cannabinoid CB2 Receptor Agonist, in IL-1β-Induced Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts
    Fechtner, Sabrina
    Singh, Anil K.
    Ahmed, Salahuddin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Cannabinoid receptor type 2 agonist JWH-133 deteriorates the liver toxicity induced by cypermethrin
    Tutun, Hidayet
    Baydan, Emine
    TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES, 2018, 42 (03): : 211 - 221
  • [36] Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
    Pacheco, Daniela da Fonseca
    Klein, Andre
    Perez, Andrea Castro
    da Fonseca Pacheco, Cinthia Mara
    de Francischi, Janetti Nogueira
    Lopes Reis, Glaucia Maria
    Gama Duarte, Igor Dimitri
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 225 - 231
  • [37] Cannabinoid CB2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice
    Souza, Camila Fernandes
    Borges, Luana Bolsoni
    Oliveira, Filipe Rodolfo Moreira Borges
    Silva, Priscila Creppas de Souza
    Patricio, Daniel Oliveira
    Rosales, Thiele Osvaldt
    Souza, Nicoly Fernandes
    Spiller, Fernando
    Mansur, Daniel Santos
    Assreuy, Jamil
    Sordi, Regina
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [38] Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
    Franks, Lirit N.
    Ford, Benjamin M.
    Prather, Paul L.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [39] Time-Dependent Protection of CB2 Receptor Agonist in Stroke
    Yu, Seong-Jin
    Reiner, David
    Shen, Hui
    Wu, Kou-Jen
    Liu, Qing-Rong
    Wang, Yun
    PLOS ONE, 2015, 10 (07):
  • [40] Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS
    Qiang Zhang
    Peng Ma
    Richard B. Cole
    Guangdi Wang
    Analytical and Bioanalytical Chemistry, 2006, 386 : 1345 - 1355
12345